Paris: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the ...

Honey bees symmetrically organize nest contents, benefiting brood development and temperature control, consistent across species. Symmetry is everywhere and serves a myriad of purposes. Humans find ...

With input from fynbos ecologists and horticulturists they are looking at which species are the easiest to kick-start an ...

A Ventura County man is trying to get his bee service business back up after more than 100 colonies were scorched in the Mountain Fire. The loss could impact the area's agricultural industry.

Hannah Glass, 19, broke out in hives and became violently ill on Nov. 5 after consuming the chocolatey treat, which contained ...

Bees have been a part of Laura Griffiths’ life for over 11 years, her beekeeping journey started in her neighbor’s land, and ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

Are we all too busy to consider making changes in our daily priorities to think about Pope Francis' call to care for creation: Laudato Si'? The climate is changing, and it is no longer a futur ...

The FDA last year turned away the companies' application and asked for additional efficacy data. Regeneron and Sanofi said the resubmission adds results from an additional Phase 3 study of Dupixent in ...

French drug major Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the U.S. Food and Drug Administration ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.